Clostridium Difficile Virulence Mechanism Study (CDVM Study)
NCT03654872 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 227
Last updated 2018-08-31
Summary
This study is an observational study to collect stool samples from patients with Clostridium difficile infection (CDI) to investigate the virulence mechanisms of C. difficile ribotypes in Hong Kong, mainly ribotype 002. No intervention is involved.
Conditions
- Clostridium Difficile Infection
- Clostridium Difficile
Sponsors & Collaborators
-
Chinese University of Hong Kong
lead OTHER
Principal Investigators
-
Dr. Sunny Wong · Institute of Digestive Disease, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-30
- Primary Completion
- 2019-05-30
- Completion
- 2019-05-30
Countries
- Hong Kong
Study Locations
More Related Trials
-
Research on Gut Microbiome and Metabolomics Alterations in C.Difficile Infected IBD Patients
NCT05714566 ·Status: RECRUITING
-
Fecal Microbiota Transplantation for CRE/VRE
NCT03479710 ·Status: COMPLETED ·Phase: PHASE2
-
Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections
NCT02774382 ·Status: UNKNOWN ·Phase: PHASE3
-
Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection
NCT03427229 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)
NCT01716533 ·Status: COMPLETED ·Phase: NA
-
Treatment of Initial Clostridium Difficile Infection
NCT03107169 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplantation for Early Clostridioides Difficile Infection
NCT04885946 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Gut Microbiota and Its Associated Resistome in FMT Donors and Recipients Due to Recurrent Clostridiodes Difficile Infection
NCT06533800 ·Status: NOT_YET_RECRUITING
-
Natural History of Clostridioides Difficile Infection
NCT04801862 ·Status: RECRUITING
-
PROSPECTIVE STUDY OF PREDISPOSING FACTORS OF REFRACTARY Clostridium Difficile INFECTION. INFLUENCE OF THE GUT MICROBIOMA
NCT04259931 ·Status: UNKNOWN
-
LMN-201 for Prevention of C. Difficile Infection Recurrence
NCT05330182 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Probiotics Administration Via Colonoscopic Spray and Oral Administration in CDAD Patients
NCT05770726 ·Status: RECRUITING ·Phase: NA
-
Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin
NCT07221708 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Pathogenic Mechanisms in C Diff Infection and Colitis
NCT01930032 ·Status: COMPLETED
-
Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics
NCT03117582 ·Status: COMPLETED
-
Response of Clostridium Difficile Infection to Metronidazole Therapy
NCT00304369 ·Status: COMPLETED
-
C.Difficile Observational Study
NCT06277999 ·Status: COMPLETED
-
A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea
NCT00034294 ·Status: COMPLETED ·Phase: PHASE2
-
The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection
NCT04668014 ·Status: COMPLETED
-
Clostridioides Difficile Infection - a Prospective Nationwide Epidemiologic Study in Korea
NCT04567134 ·Status: UNKNOWN
-
Clostridioides Difficile Controlled Human Infection Model
NCT06702345 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
NCT04675723 ·Status: COMPLETED
-
Relationship Between C. Difficile Toxins' Serum Level With C. Difficile Infection
NCT03586206 ·Status: UNKNOWN
-
Immune Response to C.Difficile Infection
NCT02797288 ·Status: UNKNOWN
-
Oral Vaccination Against Clostridium Difficile Infection
NCT02991417 ·Status: TERMINATED ·Phase: PHASE1